160 HEALTH (02656) rose over 9% against the market trend. At the time of writing, the stock was up 8.33%, trading at HKD 29.9 with a turnover of HKD 74.8819 million.

The increase follows a recent announcement from the group. From January 2025 to March 31, 2026, the company has made sustained breakthrough progress in its digital healthcare solutions business, particularly regarding the operational partnership model for its "160AI Hospital."

During this cumulative period, the number of public medical institutions that have entered into operational partnerships with the group has reached 102. This figure represents a steady increase from the 82 partnerships recorded at the end of 2025.

Among these partners, 54 are top-tier (Grade 3A) hospitals, accounting for approximately 52.9% of the total. Furthermore, the number of hospitals rated Grade 3 and above totals 78, constituting about 76.5% of all partners. This high proportion demonstrates the broad recognition and deep penetration of the group's "160AI Hospital" operational partnership model within high-end medical systems.

All these collaborations are conducted through the group's innovatively launched "160AI Hospital" operational partnership business model. As a core product of the group's digital healthcare solutions business, this model has successfully transitioned from pilot promotion to large-scale implementation. This milestone signifies a critical advancement in the group's efforts to empower the digital transformation of medical institutions and promote the intelligent upgrading of medical services.